Dianthus Therapeutics (DNTH) Change in Acquisitions & Divestments (2019 - 2025)

Dianthus Therapeutics has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $78.6 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 313.53% year-over-year to $78.6 million; the trailing twelve-month figure through Sep 2025 stood at $305.3 million (up 408.86% YoY), and the FY2024 full-year result was $127.0 million, up 63.27% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $78.6 million, up from $59.6 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $85.0 million in Q4 2024, with the low at $2.0 million in Q4 2022.
• Average Change in Acquisitions & Divestments over 5 years is $32.3 million, with a median of $20.4 million recorded in 2023.
• Year-over-year, Change in Acquisitions & Divestments plunged 94.29% in 2022 and jumped 800.0% in 2023.
• Tracing DNTH's Change in Acquisitions & Divestments over 5 years: stood at $35.0 million in 2021, then sank by 94.29% to $2.0 million in 2022, then jumped by 800.0% to $18.0 million in 2023, then soared by 372.22% to $85.0 million in 2024, then decreased by 7.56% to $78.6 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $78.6 million (Q3 2025), $59.6 million (Q2 2025), and $82.1 million (Q1 2025), per Business Quant data.

Peer Comparison